Frankfurt - Delayed Quote EUR

argenx SE (1AE.F)

Compare
600.20
+10.20
+(1.73%)
At close: 8:18:52 AM GMT+1

Research Analysis

Revenue vs. Earnings

Revenue 724.38M
Earnings 736.69M

Q1'24

Q2'24

Q3'24

Q4'24

0
200M
400M
600M
 

Analyst Price Targets

Earnings Estimate

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts --------
Avg. Estimate 0000
Low Estimate 0000
High Estimate 0000
Year Ago EPS --------

Revenue Estimate

Currency in EUR Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts 12122425
Avg. Estimate 760.62M829.54M3.4B4.31B
Low Estimate 720.75M756.39M2.94B2.5B
High Estimate 816.47M887.16M3.83B5.37B
Year Ago Sales 383.84M450.91M2.14B3.4B
Sales Growth (year/est) 98.16%83.97%58.52%26.96%

EPS Trend

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Current Estimate 0000
7 Days Ago 0000
30 Days Ago 0000
60 Days Ago 0000
90 Days Ago 0000

EPS Revisions

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
1AE.F --------
S&P 500 16.04%7.30%10.62%14.21%

Related Tickers

8AP.SG Agios Pharmaceuticals Inc
31.40
-4.27%
 
2QK.F Scholar Rock Holding Corporation
34.40
0.00%
 
ISI.F Ionis Pharmaceuticals, Inc.
31.80
+6.21%
 
ISI.MU Ionis Pharmaceuticals Inc
31.83
+4.74%
 
UNC.MU UCB SA
191.55
+5.71%
 
UCBb.XC
 
UCBJF UCB SA
201.97
+5.19%
 
VX1.F Vertex Pharmaceuticals Incorporated
466.05
+0.17%
 
ONTTF Oxford Nanopore Technologies plc
1.3500
-11.18%
 
BHVN Biohaven Ltd.
32.06
-13.77%